{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:03:11Z","timestamp":1788832991164,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2439,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Most patients with acute heart failure (AHF) are treated with supplemental oxygen during hospitalization. In this study, we investigated the effect of oxygen titrated to high vs. low pulse oximetry targets in patients hospitalized with AHF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In a pilot, open-label randomized controlled trial (RCT), 50 patients who were admitted with AHF were randomized to either high (\u226596%) or low (90\u201392%) SpO2 targets. Oxygen was manually titrated to the assigned target ranges for 72 h. The primary endpoint was the change in N-terminal pro-brain-type natriuretic peptide (NT-proBNP) from randomization to 72 h, and secondary endpoints included patient-reported dyspnoea by visual analogue scale (VAS), patient global assessment (PGA), peak expiratory flow (PEF) within 72 h, and clinical outcomes up to 30 days following hospital discharge. The median age was 73.5 years, and 42% were women. The change in NT-proBNP was \u22126963 (\u221213 345, \u22121253) pg\/mL in the high SpO2 group and \u22122093 (\u22125692, \u2212353) pg\/mL in the low SpO2 group (P = 0.46), and the 72 h to baseline NT-proBNP ratio was similar between groups (0.7 vs. 0.6, P = 0.51). There were no differences between arms in change in dyspnoea VAS (P = 0.86), PGA (P = 0.91), PEF (P = 0.52), in-hospital mortality (4.0% vs. 8.0%, P = 0.50), or 30 day heart failure readmission rates (20.8% vs. 8.7%, P = 0.22).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, no differences were observed in the primary or secondary outcomes for patients randomized to high vs. low SpO2 targets. Further RCTs with larger sample sizes are warranted to determine the efficacy and safety of oxygen therapy in patients with AHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12448","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:09:34Z","timestamp":1558138174000},"page":"667-677","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["High vs. Low Oxygen Therapy in Patients with Acute Heart Failure: HiLo-HF Pilot Trial"],"prefix":"10.1093","volume":"6","author":[{"given":"Nariman","family":"Sepehrvand","sequence":"first","affiliation":[{"name":"Canadian VIGOUR Centre, University of Alberta , 2-132 Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta , , T6G 2E1","place":["Canada"]},{"name":"Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendimagegn","family":"Alemayehu","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre, University of Alberta , 2-132 Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta , , T6G 2E1","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]},{"name":"Department of Emergency Medicine and School of Public Health, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finlay A.","family":"McAlister","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre, University of Alberta , 2-132 Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta , , T6G 2E1","place":["Canada"]},{"name":"Patient Health Outcomes Research and Clinical Effectiveness Unit, University of Alberta , Edmonton, Alberta ,","place":["Canada"]},{"name":"Division of General Internal Medicine, Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"van Diepen","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre, University of Alberta , 2-132 Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta , , T6G 2E1","place":["Canada"]},{"name":"Division of Cardiology, Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]},{"name":"Department of Critical Care Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stickland","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre, University of Alberta , 2-132 Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta , , T6G 2E1","place":["Canada"]},{"name":"Division of Cardiology, Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"2026012115093639700_ehf212448-bib-0001","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012115093639700_ehf212448-bib-0002","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2011.11.061","article-title":"Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow","volume":"59","author":"Ezekowitz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026012115093639700_ehf212448-bib-0003","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jchf.2016.03.026","article-title":"Oxygen therapy in patients with acute heart failure friend or foe?","volume":"4","author":"Sepehrvand","year":"2016","journal-title":"Jacc-Heart Failure"},{"key":"2026012115093639700_ehf212448-bib-0004","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ahj.2009.05.037","article-title":"Systematic review of studies of the effect of hyperoxia on coronary blood flow","volume":"158","author":"Farquhar","year":"2009","journal-title":"Am Heart J"},{"key":"2026012115093639700_ehf212448-bib-0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0735-1097(95)00474-2","article-title":"Hemodynamic effects of supplemental oxygen administration in congestive heart failure","volume":"27","author":"Haque","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2026012115093639700_ehf212448-bib-0006","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1378\/chest.120.2.467","article-title":"Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure","volume":"120","author":"Mak","year":"2001","journal-title":"Chest"},{"key":"2026012115093639700_ehf212448-bib-0007","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2009.175257","article-title":"Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction","volume":"96","author":"Park","year":"2010","journal-title":"Heart"},{"key":"2026012115093639700_ehf212448-bib-0008","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1706222","article-title":"Oxygen therapy in suspected acute myocardial infarction","volume":"377","author":"Hofmann","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012115093639700_ehf212448-bib-0009","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/heartjnl-2018-313089","article-title":"Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials","volume":"104","author":"Sepehrvand","year":"2018","journal-title":"Heart"},{"key":"2026012115093639700_ehf212448-bib-0010","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.114.014494","article-title":"Air versus oxygen in ST-segment-elevation myocardial infarction","volume":"131","author":"Stub","year":"2015","journal-title":"Circulation"},{"key":"2026012115093639700_ehf212448-bib-0011","first-page":"1342","article-title":"2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026012115093639700_ehf212448-bib-0012","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"2026012115093639700_ehf212448-bib-0013","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115093639700_ehf212448-bib-0014","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2026012115093639700_ehf212448-bib-0015","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/eurjhf\/hft095","article-title":"Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document","volume":"15","author":"Zannad","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012115093639700_ehf212448-bib-0016","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCHEARTFAILURE.109.893222","article-title":"Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward","volume":"3","author":"Felker","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026012115093639700_ehf212448-bib-0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"2026012115093639700_ehf212448-bib-0018","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012115093639700_ehf212448-bib-0019","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.170","article-title":"Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome\u2014an analysis from RELAX-AHF","volume":"16","author":"Voors","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012115093639700_ehf212448-bib-0020","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4187\/respcare.01343","article-title":"Automated oxygen flow titration to maintain constant oxygenation","volume":"57","author":"Lellouche","year":"2012","journal-title":"Respir Care"},{"key":"2026012115093639700_ehf212448-bib-0021","first-page":"1","article-title":"Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure","volume":"19","author":"Clark","year":"2015","journal-title":"Health Technol Assess"},{"key":"2026012115093639700_ehf212448-bib-0022","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/heartjnl-2015-308932","article-title":"The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure","volume":"102","author":"Koshy","year":"2016","journal-title":"Heart"},{"key":"2026012115093639700_ehf212448-bib-0023","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2018.05.029","article-title":"Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction","volume":"268","author":"Shah","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026012115093639700_ehf212448-bib-0024","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.resuscitation.2014.09.011","article-title":"HyperOxic Therapy OR NormOxic Therapy after out-of-hospital cardiac arrest (HOT OR NOT): a randomised controlled feasibility trial","volume":"85","author":"Young","year":"2014","journal-title":"Resuscitation"},{"key":"2026012115093639700_ehf212448-bib-0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.resuscitation.2005.08.010","article-title":"Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study","volume":"69","author":"Kuisma","year":"2006","journal-title":"Resuscitation"},{"key":"2026012115093639700_ehf212448-bib-0026","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/s13054-014-0711-x","article-title":"Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis","volume":"18","author":"Damiani","year":"2014","journal-title":"Crit Care"},{"key":"2026012115093639700_ehf212448-bib-0027","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13054-015-1067-6","article-title":"Associations of arterial carbon dioxide and arterial oxygen concentrations with hospital mortality after resuscitation from cardiac arrest","volume":"19","author":"Helmerhorst","year":"2015","journal-title":"Crit Care"},{"key":"2026012115093639700_ehf212448-bib-0028","doi-asserted-by":"crossref","first-page":"e59274","DOI":"10.1371\/journal.pone.0059274","article-title":"The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke\u2014effect on key outcomes at six months","volume":"8","author":"Ali","year":"2014","journal-title":"PLoS ONE"},{"key":"2026012115093639700_ehf212448-bib-0029","doi-asserted-by":"crossref","first-page":"e6976","DOI":"10.1136\/bmj.e6976","article-title":"Does routine oxygen supplementation in patients with acute stroke improve outcome?","volume":"345","author":"Pountain","year":"2012","journal-title":"BMJ"},{"key":"2026012115093639700_ehf212448-bib-0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/01616412.2018.1454091","article-title":"The effect of normobaric oxygen in patients with acute stroke: a systematic review and meta-analysis","volume":"40","author":"Ding","year":"2018","journal-title":"Neurol Res"},{"key":"2026012115093639700_ehf212448-bib-0031","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.2016.11993","article-title":"Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the Oxygen-ICU Randomized Clinical Trial","volume":"316","author":"Girardis","year":"2016","journal-title":"JAMA"},{"key":"2026012115093639700_ehf212448-bib-0032","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1604344","article-title":"A randomized trial of long-term oxygen for COPD with moderate desaturation","volume":"375","author":"Albert","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012115093639700_ehf212448-bib-0033","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(18)30479-3","article-title":"Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis","volume":"391","author":"Chu","year":"2018","journal-title":"Lancet"},{"key":"2026012115093639700_ehf212448-bib-0034","article-title":"Oxygen therapy for acutely ill medical patients: a clinical practice guideline","volume":"363","author":"Siemieniuk","year":"2018","journal-title":"BMJ"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12448","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/4\/667\/66136603\/eschf_6_4_667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/4\/667\/66136603\/eschf_6_4_667.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:12:35Z","timestamp":1769026355000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/6\/4\/667\/8403575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,5,17]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12448","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"2019-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}